Lipoprotein(a) lowering by alirocumab reduces the total...

  • Main
  • 2020 / 10
  • Lipoprotein(a) lowering by alirocumab reduces the total...

Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial

Szarek, Michael, Bittner, Vera A, Aylward, Philip, Baccara-Dinet, Marie, Bhatt, Deepak L, Diaz, Rafael, Fras, Zlatko, Goodman, Shaun G, Halvorsen, Sigrun, Harrington, Robert A, Jukema, J Wouter, Moria
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
European Heart Journal
DOI:
10.1093/eurheartj/ehaa649
Date:
October, 2020
File:
PDF, 912 KB
2020
Conversion to is in progress
Conversion to is failed